Knoll Capital Management as of Dec. 31, 2020
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 31 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Biohaven Pharmaceutical Holding | 50.1 | $74M | 858k | 85.71 | |
Applied Therapeutics (APLT) | 12.8 | $19M | 852k | 22.02 | |
Eiger Biopharmaceuticals | 5.8 | $8.5M | 694k | 12.29 | |
Corbus Pharmaceuticals Hldgs | 4.3 | $6.3M | 5.0M | 1.25 | |
Orgenesis | 4.0 | $5.9M | 1.3M | 4.50 | |
Abeona Therapeutics | 3.1 | $4.5M | 2.9M | 1.57 | |
Aldeyra Therapeutics (ALDX) | 2.7 | $3.9M | 569k | 6.86 | |
Anavex Life Sciences Corp Com New (AVXL) | 2.5 | $3.6M | 671k | 5.40 | |
Blackstone Group Com Unit Ltd | 1.8 | $2.6M | 40k | 64.80 | |
Exicure | 1.5 | $2.3M | 1.3M | 1.77 | |
CenturyLink | 1.5 | $2.1M | 220k | 9.75 | |
Entera Bio SHS (ENTX) | 1.3 | $1.9M | 1.7M | 1.08 | |
Dow (DOW) | 1.1 | $1.7M | 30k | 55.50 | |
Corteva (CTVA) | 0.8 | $1.2M | 30k | 38.73 | |
Molecular Templates | 0.7 | $1.1M | 114k | 9.39 | |
Dupont De Nemours (DD) | 0.7 | $1.1M | 15k | 71.13 | |
Soligenix | 0.7 | $1.0M | 788k | 1.28 | |
Bioxcel Therapeutics (BTAI) | 0.6 | $924k | 20k | 46.20 | |
Seabridge Gold (SA) | 0.5 | $674k | 32k | 21.06 | |
Maverix Metals Com New | 0.4 | $628k | 115k | 5.46 | |
Altimmune Com New (ALT) | 0.4 | $564k | 50k | 11.28 | |
Osisko Gold Royalties (OR) | 0.4 | $551k | 190k | 2.90 | |
Agnico (AEM) | 0.3 | $487k | 6.9k | 70.58 | |
Equinox Gold Corp equities (EQX) | 0.3 | $470k | 46k | 10.33 | |
Franco-Nevada Corporation (FNV) | 0.3 | $470k | 3.8k | 125.33 | |
Kirkland Lake Gold | 0.3 | $444k | 11k | 41.30 | |
Fortuna Silver Mines | 0.2 | $360k | 44k | 8.24 | |
Mag Silver Corp (MAG) | 0.2 | $355k | 17k | 20.52 | |
Silvercrest Metals (SILV) | 0.2 | $347k | 31k | 11.19 | |
Pan American Silver Corp Can (PAAS) | 0.2 | $283k | 8.2k | 34.51 | |
Silvercorp Metals (SVM) | 0.2 | $244k | 37k | 6.68 |